Literature DB >> 17525583

A series of anesthesia-related maternal deaths in Michigan, 1985-2003.

Jill M Mhyre1, Monica N Riesner, Linda S Polley, Norah N Naughton.   

Abstract

BACKGROUND: Maternal Mortality Surveillance has been conducted by the State of Michigan since 1950, and anesthesia-related maternal deaths were most recently reviewed for the years 1972-1984.
METHODS: Records for pregnancy-associated deaths between 1985 and 2003 were reviewed to identify 25 cases associated with a perioperative arrest or major anesthetic complication. Four obstetric anesthesiologists independently classified these cases, and disagreements were resolved by discussion. Precise definitions of anesthesia-related and anesthesia-contributing maternal death were constructed. Anesthesia-related deaths were reviewed to identify the chain of medical errors or care management problems that contributed to each patient death.
RESULTS: Of 855 pregnancy-associated deaths, 8 were anesthesia-related and 7 were anesthesia-contributing. There were no deaths during induction of general anesthesia. Five resulted from hypoventilation or airway obstruction during emergence, extubation, or recovery. Lapses in either postoperative monitoring or anesthesiology supervision seemed to contribute to 5 of the 8 anesthesia-related deaths. Other characteristics common to these cases included obesity (n=6) and African-American race (n=6).
CONCLUSIONS: The 8 anesthesia-related and seven anesthesia-contributing maternal deaths in Michigan between 1985 and 2003 illustrate three key points. First, all anesthesia-related deaths from airway obstruction or hypoventilation took place during emergence and recovery, not during the induction of general anesthesia. Second, system errors played a role in the majority of cases. Of concern, lapses in postoperative monitoring and inadequate supervision by an anesthesiologist seemed to contribute to more than half of the deaths. Finally, this report confirms previous work that obesity and African-American race are important risk factors for anesthesia-related maternal mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17525583     DOI: 10.1097/01.anes.0000267592.34626.6b

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  26 in total

1.  Incidence of unanticipated difficult airway in obstetric patients in a teaching institution.

Authors:  Weike Tao; Jason T Edwards; Faping Tu; Yang Xie; Shiv K Sharma
Journal:  J Anesth       Date:  2012-01-31       Impact factor: 2.078

2.  Keep our guard up against general anesthesia for cesarean section!

Authors:  Hiroyuki Sumikura
Journal:  J Anesth       Date:  2012-05-19       Impact factor: 2.078

3.  Elevated body position early after delivery increased airway size during wakefulness, and decreased apnea hypopnea index in a woman with pregnancy related sleep apnea.

Authors:  Stefanie Jung; Sebastian Zaremba; Anne Heisig; Matthias Eikermann
Journal:  J Clin Sleep Med       Date:  2014-07-15       Impact factor: 4.062

4.  [Surveillance following anesthesia procedures : Comments on the new recommendations of the German Society for Anesthesiology and Intensive Care medicine and the Professional Association of German Anesthetists].

Authors:  M Wehner
Journal:  Anaesthesist       Date:  2010-02       Impact factor: 1.041

5.  The effect of preeclampsia on the skin to subarachnoid distance in spinal anesthesia.

Authors:  B Basaran; A Basaran; B Kozanhan; S Ozmen; M Basaran
Journal:  J Anesth       Date:  2014-11-07       Impact factor: 2.078

Review 6.  General anaesthesia in obstetrics.

Authors:  C Delgado; L Ring; M C Mushambi
Journal:  BJA Educ       Date:  2020-04-21

7.  Anesthetic practices for patients with preeclampsia or HELLP syndrome: A survey.

Authors:  Betül Başaran; Bilge Çelebioğlu; Ahmet Başaran; Seher Altınel; Leyla Kutlucan; James N Martin
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-09-01

8.  Disrupted sleep and delayed recovery from chronic peripheral neuropathy are distinct phenotypes in a rat model of metabolic syndrome.

Authors:  Aaron R Muncey; Adam R Saulles; Lauren G Koch; Steven L Britton; Helen A Baghdoyan; Ralph Lydic
Journal:  Anesthesiology       Date:  2010-11       Impact factor: 7.892

Review 9.  HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Statins in the treatment of polycystic ovary syndrome.

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Semin Reprod Med       Date:  2008-01       Impact factor: 1.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.